Journal of Obstetrics and Gynaecology · 1996 · 13 citations · 11 references
MedicineGynecologyObstetricsMaternal-fetal MedicineObstetric ComplicationsReproductive MedicineIntrapartum ComplicationsMaternal ComplicationsMaternal Medical Complications In PregnancyObstetric ManagementPregnancyInduction Of Labor ComplicationsIntrauterine Fetal DeathMisoprostol TherapyMisoprostol Use In AbortionOxytocin Use
SummarySummaryBetween March 1992 and November 1994, 48 patients with intrauterine death had labour induced, 36 with the prostaglandin analogue misoprostol and 12 with the prostaglandin dinoprostone. Both were used as a single dose in 24 hours intravaginally. The patients were all of low parity and all but one were in the third trimester. Of those getting misoprostol, 92 per cent, and of those getting dinoprostone, 67 per cent, went into spontaneous labour. Eighty-one per cent of those getting misoprostol and 67 per cent of those getting dinoprostone delivered within 24 hours without the need for further prostaglandin or oxytocin, a difference that was not significant. No differences were found in other outcome variables such as diagnosis or induction to delivery time or need for oxytocin, between the two groups. Only one maternal medical complication occurred, chorioamnionitis in a patient who had misoprostol, and in whom labour was delayed 6 days.
11
Journal of the American College of Surgeons · 2023 · 542 citations
Edward J. Quilligan · JAMA · 1995 · 341 citations
PROGRESS IN OBSTETRICS AND GYNÆCOLOGY
The Medical Journal of Australia · 1944 · 244 citations · Full text
Medicine, Gynecology, Obstetrics +12